Synthesis and biological evaluation of silylated mixed-ligand 99mTc complexes with the [PNS/S] donor atom set

Nuclear Medicine and Biology

Volumn 31, Issue 6, 2004, Pages 785-793

  Fernandes, C ^a   Kniess, T ^a   Gano, L ^a   Seifert, S ^b   Spies, H ^b   Santos, I ^a  

^a INSTITUTO TECNOLÓGICO E NUCLEAR   (Portugal)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

99mTc; Biological evaluation; Mixed ligand complexes

Indexed keywords

GLUTATHIONE; OXYGEN; PHOSPHINE; PLASMA PROTEIN; RHENIUM; SILICON; SODIUM CHLORIDE; STANNOUS CHLORIDE; TECHNETIUM 99M; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; ATOM; CHEMICAL BOND; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOUSE; NONHUMAN; PURIFICATION; RADIOCHEMISTRY; RAT; SILYLATION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FEMALE; GLUTATHIONE; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; INDICATORS AND REAGENTS; ISOTOPE LABELING; LIPIDS; MICE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; SILANES; SILICON; SPECTROPHOTOMETRY, ATOMIC; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION;

EID: 3042836911     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.03.011     Document Type: Article

References (17)

1. Beckett A.H., Taylor D.C., Garrod J.W. Trialkylsily moieties as potencial pharmacokinetic modifying groups for aminoalchohols. J Pharm Pharmacol. 27:1975;588-593
2. Millership J.S., Shanks M.L. Prodrugs utilizing organosilyl derivation an investigation of the long-term androgenic and myotrophic activities of silyl derivatives of testosterone. J Pharm Sci. 77:1988;116-119
3. Przuntek H., Westarp M.E., Vohl M.L., Gerlach M., Jutzi P., Wekerle H. The effect of silyl substituted methotrexate in the treatment of experimental allergic encephalomyelitis in rats mediated by T-line cells. Neuropharmacology. 26:1987;255-260
4. Tsareva T.A., Kramarova E.P., Zharkovskii A.M. Pharmacological characteristics of the silyl derivatives of alpha-pyrrolidone. Farmakol Toksikol. 45:1982;20-23
5. Fietz Th, Spies H, Zablotskaya A, Scheller D. Reactions of hydroxy-group containing '3 + 1' mixed-ligand rhenium(V) compounds. Part 1: Silylation of '3 + 1' mixed-ligand complexes. Inst Bioanorg Radiopharm Chemie, FZ-Rossendorf, Annual Report, 1997;113-16
6. 99mTc)technetium '3 + 1' mixed ligand complexes. J Label Comp Radiopharm. 45:2002;629-636
7. Spies H., Fietz T.h, Zablotska A., Belyakov S., Lukevics E. Silyl modifications of biologically active compounds. Organosilicon complexes of rhenium(V) with mixed ligands. Chem Het Comp. 35:1999;112-120
8. 99mTc(V) "3 + 1" mixed-ligand complexes towards glutathione. Radiochim Acta. 89:2001;43-49
9. Syhre R., Seifert S., Spies H., Gupta A., Johannsen B. Stability versus reactivity of "3 + 1" mixed-ligand technetium-99m complexes in vitro and in vivo. Eur J Nucl Med. 25:1998;793-796
10. Correia J.D.G., Domingos A., Santos I., Alberto R., Ortner K. Re tricarbonyl complexes with ligands containing P, N, N and P, N, O donor atom sets synthesis and structural characterization. Inorg Chem. 40:2001;5147-5151
11. Correia J.D.G., Domingos A., Santos I., Spies H. Synthesis and characterization of mixed-ligand oxorhenium(V) complexes with new [(PNO/S)/(S)] donor atom sets. J Chem Soc Dalton Trans. 2001:2001;2245-2250
12. + (M=Re, Tc) moiety. J Label Comp Radiopharm. 44:2001;S507-509
13. 1A receptor-binding ligand. J Labeled Comp Radiopharm. 44:2001;S518-520
14. Kniess T., Fernandes C., Santos I., Spies H., Kraus W. Silylated mixed-ligand rhenium complexes with the [PNS/S] donor atom set. Inorg Chim Acta. 348:2003;237-241
15. 3]. J Organomet Chem. 493:1995;119-127
16. 99mTc(V) complexes with SH group-containing proteins. Appl Radiat Isot. 54:2001;637-644
17. Kniess T, Fernandes C, Seifert S, Spies H, Santos I. unpublished results